Pazdur To Oncology Drug Developers: Step Back, Slow Down – And Find The Right Dose

 
• By Kate Rawson
Cancer cells on scientific background.3d illustration
Waiting to address dosing issues post approval will not be an option in the future. • Source: Shutterstock

More from Clinical Trials

More from R&D